Patent application number | Description | Published |
20110028457 | PHARMACEUTICAL PREPARATION COMPRISING PERMETHYLATED CYCLODEXTRIN - The invention relates to a pharmaceutical preparation for applying a pharmaceutical agent. According to the invention, the preparation contains: a) a pharmaceutical agent which has an aromatic group or an aromatic part and the molecule of which has a maximum diameter of ≦2 nm; b) a permethylated cyclodextrin having a degree of substitution of 3 methyl groups per glucopyranose unit. The permethylated cyclodextrin and the pharmaceutical agent form a complex. | 02-03-2011 |
20120296077 | HALOGENATED ETHER COMPLEX - The invention relates to a complex made of α-cyclodextrin and a halogenated ether, characterized by a content of the halogenated ether of at least 3 wt % of the total weight of the complex. | 11-22-2012 |
20130316976 | PHARMACEUTICAL PREPARATION - The invention relates to a pharmaceutical formulation that contains a complex of a propofol salt with a cyclodextrin. The invention makes it possible to provide propofol in a formulation that can be stored and that can be administered intravenously without problems. | 11-28-2013 |
20150051273 | USE OF DELPHINIDIN AGAINST STAPHYLOCOCCUS AUREUS - The invention relates to the use of delphinidin or salts thereof, which is aimed at bacteria selected from the group comprising antibiotic-resistant | 02-19-2015 |
20150087822 | ANTHOCYANIDIN COMPLEX - The invention relates to a complex of pure anthocyanidin and a sulfoalkyl ether β-cyclodextrin, which complex can be formulated as an aqueous solution and as a solid, and a method for producing such a complex. Complexes according to the invention are storage-stable and can be well formulated as an aqueous solution. | 03-26-2015 |
20150306247 | DELPHINIDIN COMPLEX AS AN ANTIPHLOGISTIC OR IMMUNOSUPPRESSIVE ACTIVE INGREDIENT - The invention relates to a composition comprising a complex of delphinidin and a sulfoalkyl ether β-cyclodextrin for use as an antiphlogistic and/or immunosuppressive. | 10-29-2015 |
20150320719 | DELPHINIDIN FOR COMBATING MELANOMA CELLS - The invention relates to a composition comprising: a complex of delphinidin and a sulfoalkyl ether-β-cyclodextrin and/or delphinidin and the salts thereof as a first component; and a tumour-necrosis factor related apoptosis-inducing ligand (TRAIL) as a second component, for use in the treatment of malignant melanoma. | 11-12-2015 |
20150328336 | DELPHINIDIN FOR COMBATING MELANOMA CELLS - The invention relates to a composition comprising a complex of delphinidin and a sulfoalkyl ether-β-cyclodextrin for use in the treatment of malignant melanoma. | 11-19-2015 |